Medical Economics Co. Launches New Magazine

Posted on June 13, 1997

Medical Economics Company has unveiled a new monthly magazine -- Strategic Medicine -- that will help physicians meet the clinical challenges associated with the delivery of cost-effective, quality healthcare. The inaugural issue of Strategic Medicine is slated for September 1997. Strategic Medicine will assist primary care physicians in managed care settings with the task of balancing responsibility to the individual patient with the reality of allocating finite resources across a population of patients.

"Strategic Medicine is the first magazine of its kind in that it addresses the full range of medical, legal, ethical, and human issues that clinicians encounter in population-based care," says James R. Pantaleo, Publisher.

Feature articles will provide a rational, scientific basis for cost-effective decisions in managing disease states. Departments will address legal, ethical, patient relations, and other issues that are inherent in strengthening physician control over managed care.

"Our research indicates that physicians need useful, authoritative, and timely information and guidance about the cost-effective, clinical management of disease," notes Pantaleo. "Strategic Medicine empowers primary care physicians to take ownership of the practice guidelines that managed care medical directors want them to use."

The publication will focus on:

-- Outcomes management

-- Use of clinical guidelines

-- Wellness and prevention

-- Healthcare team approach

Magazine editorial will be guided by Richard Service, Group Editor, and will be developed and reviewed with an editorial advisory board of MDs, PhDs, PharmDs, and case managers in various clinical and academic appointments. Strategic Medicine's panel brings to the publication in-depth knowledge of medical outcomes, coordinated care, integrated patient centered care, clinical practice improvement, disease management, utilization review, and a host of disease states, including asthma, diabetes, cardiovascular disease, depression, cancer, and infectious diseases.

Strategic Medicine will initially reach more than 65,000 primary care physicians, medical directors, pharmacy directors, and managed care executives.